The Future of Food in Asia and Alternative Proteins

Proterra Investment Partners The Future of Food in Asia and Alternative Proteins

 

Proterra Investment Partners

Plant-based alternatives to conventional proteins have grown steadily in popularity in developed economies like North America and Europe over the past decades. The plant-based alternative sector’s growth was led by plant-based milks (e.g., soy, almond, oat, hemp), which has already grown to 14% share of the US retail milk industry. The US plant-based milk market alone was valued at USD 2.0 billion in 2019 and growing as it becomes increasingly available to the mainstream consumer, with foodservice adoption moving from specialty coffee shops to specialty coffee chains (like Starbucks) to mainstream chains (like Dunkin’, which just added oat milk as an option to all US locations in August 2020). 

We believe Asia presents a tremendous opportunity for the sector as the most recent wave of modern alternative proteins that have emerged in the West over the past 5 to 10 years has only just begun to take root.

 

View the full article here 

 

The information in this document is current as of the date of publication and is provided solely by Proterra Investment Partners LP and its affiliates (“Proterra”).

This document is for informational and discussion purposes only and has been prepared without taking into account any person’s objectives, financial situation or needs. Any person receiving the information in this document should consider the appropriateness of the information, in light of their own objectives, financial situation or needs before acting.

These materials do not constitute an offer to sell, or a solicitation of an offer to buy interests in any product or fund offered by Proterra. Any such offer or solicitation may only be made by the authorized delivery of a confidential private placement memorandum, which would contain material information not contained herein, including a description of certain material terms, confidentiality covenants, risk factors, conflicts of interest, investment considerations and tax, legal, regulatory, and other important disclosures.